US Stocks
/
GRAIL, Inc. Share Price
GRAIL, Inc. Share Price

GRAIL, Inc. Share Price

NASDAQ: GRAL | Mid Cap
$80.73
+$1.01 (1.27%) Last updated on 19 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

GRAIL, Inc. Stock Performance

Open
$80.81
Prev. Close
$79.72
Circuit Range
N/A
Day Range
$78.29 - $82.68
Year Range
$39.09 - $118.12
Volume
1,03,575
Average Traded
$80.64

GRAIL, Inc. Share Price Today

As of 20 September 2026, GRAIL, Inc.'s share price is $80.73. The stock opened at $80.81, compared to its previous close of $79.72. During today's trading session, GRAIL, Inc.'s share price traded between $78.29 and $82.68, with an average price of $80.49. Over the past 52 weeks, the stock has recorded a high of $118.12 and a low of $39.09. In terms of performance, GRAIL, Inc.'s share price has risen by 56.20% over the last six months and is up 36.65% on a year-on-year basis.

GRAIL, Inc. Share Price Chart

$78.29$82.68
L
Show Current Price
H

GRAIL, Inc. Stock Fundamentals & Key Indicators

Market Cap
$2.97B
PE Ratio (TTM)
-7.27
Dividend Yield
N/A
EPS (TTM)
$-11.11
Revenue (TTM)
$147.17M
Return On Equity (TTM)
-15.84%
Profit Margin
-277.47%
Debt to Equity
0.03
Quarterly Earnings Growth YoY
29.21%

GRAIL, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsJun 2024Sep 2024Mar 2025Jun 2025Sep 2025
Revenue$31.97M$28.65M$31.84M$35.54M$36.19M
Net Profit-$1.59B-$125.69M-$106.21M-$113.98M-$88.98M
Net Profit Margin-4958.83%-438.67%-333.61%-320.69%-245.83%
Income ChangeN/A92.07%15.49%-7.32%21.94%

GRAIL, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$125.59M$147.17M
Net Profit-$2.03B-$408.35M
Net Profit Margin-1613.92%-277.47%
Income ChangeN/A79.85%

About GRAIL, Inc.

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, it develops minimal residual disease post-diagnostic tests. The company was incorporated in 2015 and is headquartered in Menlo Park, California.

GRAIL, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$78.95
$80.70
-2.07%
Aug 2026
$67.56
$82.41
+20.25%
Jul 2026
$68.77
$68.53
+0.54%
Jun 2026
$58.39
$68.17
-4.92%
May 2026
$53.80
$71.69
+31.59%
Apr 2026
$52.09
$54.48
+5.41%
Mar 2026
$49.53
$51.69
-2.91%
Feb 2026
$99.49
$53.23
-45.48%
Jan 2026
$86.50
$97.64
+14.05%
Dec 2025
$105.86
$85.61
-22.51%
Nov 2025
$89.56
$110.48
+20.22%
Oct 2025
$59.17
$91.90
+55.55%

GRAL Share Price FAQs

What is GRAIL, Inc. share price today?

chevron-up
GRAIL, Inc. share price today is $80.73 as on September 19, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of GRAIL, Inc. stock?

chevron-up
The 52 week high of GRAIL, Inc. stock is $118.12, while the 52 week low is $39.09 as of 19 Sep '26.

What is GRAL's market capitalisation today?

chevron-up
GRAL market capitalisation is $2.97B as of September 20, 2026, at 2:38 pm IST.

What is GRAL's net income for the last quarter?

chevron-up
GRAL's net income for the last quarter is -0.09B USD.

What is the 5 year returns of GRAL?

chevron-up
The 5 year returns of GRAL is 425.24% as on 19 Sep '26.

What is the high & low stock price of GRAL today?

chevron-up
GRAL stock price hit a high of $82.68 and low of $78.29 as of 19 Sep '26.

Can I buy GRAL shares in India?

chevron-up
Yes. You can buy GRAL in India by opening an international trading account.